- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 30.88M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 23.57M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 4.83M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$11.81M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$12.04M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $77.86M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $84.66M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $22.43M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $24.93M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $17.18M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $28.42M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$105.54M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$95.46M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$90.17M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$93.1M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $54.99M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $53.93M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $139.57M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $140.38M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $33.91M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $44.69M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $34.03M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $44.92M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.54 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.50 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.54 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.50 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $7.19M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $5.7M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.96M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $4.55M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$12.69M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$7.25M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$10.22M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$10.1M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $283K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $14K |
| Revenue | Q1 2026 · Mar 31, 2026 | $206K |
| Revenue | Q1 2026 · Mar 31, 2025 | $168K |